FARMAKOTERAPI PADA GANGGUAN MATA. GENERAL PRINCIPLES OF TREATMENT Drug treatment in ophthalmology is...

63
FARMAKOTERAPI PADA GANGGUAN MATA

Transcript of FARMAKOTERAPI PADA GANGGUAN MATA. GENERAL PRINCIPLES OF TREATMENT Drug treatment in ophthalmology is...

Page 1: FARMAKOTERAPI PADA GANGGUAN MATA. GENERAL PRINCIPLES OF TREATMENT Drug treatment in ophthalmology is largely directed to one of the following approaches:

FARMAKOTERAPI PADA GANGGUAN

MATA

Page 2: FARMAKOTERAPI PADA GANGGUAN MATA. GENERAL PRINCIPLES OF TREATMENT Drug treatment in ophthalmology is largely directed to one of the following approaches:

GENERAL PRINCIPLES OF TREATMENT

Drug treatment in ophthalmology is largely directed to one of the following approaches:

1. Reduction of inflammation by prompt and intensive treatment of microbial infection

2. Reduction of raised intraocular pressure3. Removal of an opacified corneal epitelium4. Physiological replacement of tear5. Intraocular fluid replacement

Page 3: FARMAKOTERAPI PADA GANGGUAN MATA. GENERAL PRINCIPLES OF TREATMENT Drug treatment in ophthalmology is largely directed to one of the following approaches:

ANATOMI MATA

Page 4: FARMAKOTERAPI PADA GANGGUAN MATA. GENERAL PRINCIPLES OF TREATMENT Drug treatment in ophthalmology is largely directed to one of the following approaches:
Page 5: FARMAKOTERAPI PADA GANGGUAN MATA. GENERAL PRINCIPLES OF TREATMENT Drug treatment in ophthalmology is largely directed to one of the following approaches:

Lacrimal Apparatus

Page 6: FARMAKOTERAPI PADA GANGGUAN MATA. GENERAL PRINCIPLES OF TREATMENT Drug treatment in ophthalmology is largely directed to one of the following approaches:
Page 7: FARMAKOTERAPI PADA GANGGUAN MATA. GENERAL PRINCIPLES OF TREATMENT Drug treatment in ophthalmology is largely directed to one of the following approaches:

Normal aqueous flow

Page 8: FARMAKOTERAPI PADA GANGGUAN MATA. GENERAL PRINCIPLES OF TREATMENT Drug treatment in ophthalmology is largely directed to one of the following approaches:
Page 9: FARMAKOTERAPI PADA GANGGUAN MATA. GENERAL PRINCIPLES OF TREATMENT Drug treatment in ophthalmology is largely directed to one of the following approaches:

CATARACTS

• Is defined as any opacity in the crystalline lens of the eye

• Blindness

Causa:• Diabetes mellitus• Ultraviolet light• Trauma• Drugs• Age • Congenital • Ocular Surgery

Page 10: FARMAKOTERAPI PADA GANGGUAN MATA. GENERAL PRINCIPLES OF TREATMENT Drug treatment in ophthalmology is largely directed to one of the following approaches:

Drugs

Chlorpromazine

• Long-acting mioticsOther drugs

• Amiodarone• Busulphan

- initially posterior subcapsularSystemic or topical steroids

- central, anterior capsular granules

Page 11: FARMAKOTERAPI PADA GANGGUAN MATA. GENERAL PRINCIPLES OF TREATMENT Drug treatment in ophthalmology is largely directed to one of the following approaches:

Symptoms• blurred vision,which is usually worse

when viewing distant objects• cannot see so well in bright light and

might even be wearing a pair of dark glasses

• look double• the vision is much worse in bright

sunlight

Page 12: FARMAKOTERAPI PADA GANGGUAN MATA. GENERAL PRINCIPLES OF TREATMENT Drug treatment in ophthalmology is largely directed to one of the following approaches:

Classification

Page 13: FARMAKOTERAPI PADA GANGGUAN MATA. GENERAL PRINCIPLES OF TREATMENT Drug treatment in ophthalmology is largely directed to one of the following approaches:

Classification according to maturity

Immature Mature

Hypermature Morgagnian

Page 14: FARMAKOTERAPI PADA GANGGUAN MATA. GENERAL PRINCIPLES OF TREATMENT Drug treatment in ophthalmology is largely directed to one of the following approaches:
Page 15: FARMAKOTERAPI PADA GANGGUAN MATA. GENERAL PRINCIPLES OF TREATMENT Drug treatment in ophthalmology is largely directed to one of the following approaches:

Anterior polar cataract May be dominant inheritance

Capsular Pyramid

With persistent pupillary membrane

With Peters anomaly

Page 16: FARMAKOTERAPI PADA GANGGUAN MATA. GENERAL PRINCIPLES OF TREATMENT Drug treatment in ophthalmology is largely directed to one of the following approaches:

Nuclear cataract

• Exaggeration of normal nuclear ageing change• Causes increasing myopia

• Increasing nuclear opacification

• Initially yellow then brown

Progression

Page 17: FARMAKOTERAPI PADA GANGGUAN MATA. GENERAL PRINCIPLES OF TREATMENT Drug treatment in ophthalmology is largely directed to one of the following approaches:

Cortical cataract

Initially vacuoles and clefts Progressive radial spoke-like opacities

Progression

Page 18: FARMAKOTERAPI PADA GANGGUAN MATA. GENERAL PRINCIPLES OF TREATMENT Drug treatment in ophthalmology is largely directed to one of the following approaches:

Subcapsular cataract

Anterior Posterior

Page 19: FARMAKOTERAPI PADA GANGGUAN MATA. GENERAL PRINCIPLES OF TREATMENT Drug treatment in ophthalmology is largely directed to one of the following approaches:
Page 20: FARMAKOTERAPI PADA GANGGUAN MATA. GENERAL PRINCIPLES OF TREATMENT Drug treatment in ophthalmology is largely directed to one of the following approaches:

Treatment:

1. To delaying the progression cataract.- Bendazac lysine 1 % ( eye drops )- Bendazac lysine 500 mg 3 times daily ( orally )2. Cataract surgery- Preoperative: To prevent constriction of the pupil

diclofenac ( topically )- Intraoperative: gentamicin ( inj. Subconjunctiva)- Post operative: corticosteroid ( topically ) + / - antibiotic ( topically),

: NSAID 1-4 weeks

Page 21: FARMAKOTERAPI PADA GANGGUAN MATA. GENERAL PRINCIPLES OF TREATMENT Drug treatment in ophthalmology is largely directed to one of the following approaches:

Treatment:

3. Local anaesthetics:

- Bupivacaine 0.25 % - 0.75 %

- Lignocaine 1 %

- Mepivacaine 1 % - 2 %

- Etidocaine 1 %

Page 22: FARMAKOTERAPI PADA GANGGUAN MATA. GENERAL PRINCIPLES OF TREATMENT Drug treatment in ophthalmology is largely directed to one of the following approaches:

GLAUCOMA• Associated with elevated intraocular

pressure (IOP )• Intra cranial pressure is set to the retinal

pressure• Optic disk cupping• Patient with IOP greater than 21 mm Hg

should be suspected of having glaucoma• the pressure of elevated IOP is not

synonymus with glaucoma,for example: tumor inside the brain.

Page 23: FARMAKOTERAPI PADA GANGGUAN MATA. GENERAL PRINCIPLES OF TREATMENT Drug treatment in ophthalmology is largely directed to one of the following approaches:

IOP and Optic disc

Page 24: FARMAKOTERAPI PADA GANGGUAN MATA. GENERAL PRINCIPLES OF TREATMENT Drug treatment in ophthalmology is largely directed to one of the following approaches:

GLAUCOMA

• Is characterized by:- The optic nerve damage is usually with elevated Intra Ocular Pressure ( IOP ) greater than 21 mm Hg- Visual field changes - Can cause blindness

• SignsThe three cardinal signs are:1. Raised intraocular pressure.2. Cupping of the optic disc.3. Visual field loss.

Page 25: FARMAKOTERAPI PADA GANGGUAN MATA. GENERAL PRINCIPLES OF TREATMENT Drug treatment in ophthalmology is largely directed to one of the following approaches:

Etiology

Causa :

Age

Miopi

Heredity

Diabetes

Drugs

Page 26: FARMAKOTERAPI PADA GANGGUAN MATA. GENERAL PRINCIPLES OF TREATMENT Drug treatment in ophthalmology is largely directed to one of the following approaches:

Classification of glaucoma

• Primary glaucoma:

1. Open angle

2. Closed angle

• Secondary glaucoma:

1. Open angle

2. Closed angle

• Congenital glaucoma

Page 27: FARMAKOTERAPI PADA GANGGUAN MATA. GENERAL PRINCIPLES OF TREATMENT Drug treatment in ophthalmology is largely directed to one of the following approaches:

GLAUCOMA

OPEN ANGLE GLAUCOMA :

1.Pathological changes in the trabecular meshwork decrease the outflow of aqueous humour

2.The primary defect is reduced drainage of the aqueous humour into canal of Schlemm

Page 28: FARMAKOTERAPI PADA GANGGUAN MATA. GENERAL PRINCIPLES OF TREATMENT Drug treatment in ophthalmology is largely directed to one of the following approaches:

GLAUCOMA

CLOSED ANGLE GLAUCOMA :

• Cause:1. The result from forward ballooning of the peripheral iris, it touches the back of cornea

2. The flow of aqueous humor between the cornea and the iris is reduced

Page 29: FARMAKOTERAPI PADA GANGGUAN MATA. GENERAL PRINCIPLES OF TREATMENT Drug treatment in ophthalmology is largely directed to one of the following approaches:

Chronic open angle glaucoma (primer)

Symptoms:

No symptom

No visual acuity complaint

Peripheral visual field loss

- difficulty in walking

- can not see anything surround

Totally blind (end state)

Page 30: FARMAKOTERAPI PADA GANGGUAN MATA. GENERAL PRINCIPLES OF TREATMENT Drug treatment in ophthalmology is largely directed to one of the following approaches:

Signs:

• Quiet eye

• Gonioscopy: normal

• Glaucomatous optic atrophy (CD > 0,6,disc hemorrhage)

• Glaucomatous visual field defects

• IOP > 21 mmHg

Page 31: FARMAKOTERAPI PADA GANGGUAN MATA. GENERAL PRINCIPLES OF TREATMENT Drug treatment in ophthalmology is largely directed to one of the following approaches:

ACUTE ANGLE CLOSURE GLAUCOMA

(primer)

Symptoms :

Severe pain

Redness

Blurred vision

Nausea

Vomiting

Page 32: FARMAKOTERAPI PADA GANGGUAN MATA. GENERAL PRINCIPLES OF TREATMENT Drug treatment in ophthalmology is largely directed to one of the following approaches:

Acute angle closure glaucoma(primer)

• Palpebral spasm• Conjungtival hyperemia• Corneal edema• Shallow anterior chamber• Pigment dispersion• Gonioscopy: closed angle• Optic nerve: hyperemic, edematous• Visual field: nonspecific constriction• High IOP (>21 mmHg)

Page 33: FARMAKOTERAPI PADA GANGGUAN MATA. GENERAL PRINCIPLES OF TREATMENT Drug treatment in ophthalmology is largely directed to one of the following approaches:

Open angle sec.glaucoma (secunder)

• Uveitis

• Hipermatur lens

• Steroid

• Trauma

Symptom Acute or chronic

Page 34: FARMAKOTERAPI PADA GANGGUAN MATA. GENERAL PRINCIPLES OF TREATMENT Drug treatment in ophthalmology is largely directed to one of the following approaches:

Closed angle secunder glaucoma

• Uveitis

• Subluxation/dislocation of lens

• Intraocular neoplasm

• Neovascularization of the angle

Symptom: acute glaucoma

Page 35: FARMAKOTERAPI PADA GANGGUAN MATA. GENERAL PRINCIPLES OF TREATMENT Drug treatment in ophthalmology is largely directed to one of the following approaches:

Congenital glaucoma

• First year of life

• Photophobia

• Buphthalmos/enlarge eye globe

• Corneal clouding

• High IOP

Saluran pembuangan tidak sempurna

Page 36: FARMAKOTERAPI PADA GANGGUAN MATA. GENERAL PRINCIPLES OF TREATMENT Drug treatment in ophthalmology is largely directed to one of the following approaches:

Glaucoma examination

Ophthalmoscopy (Optic nerve)

Tonometry (Intraocular pressure/IOP)

Gonioscopy (Anterior chamber angle)

Perimetry (Visual field)

Page 37: FARMAKOTERAPI PADA GANGGUAN MATA. GENERAL PRINCIPLES OF TREATMENT Drug treatment in ophthalmology is largely directed to one of the following approaches:

Visual field loss in glaucoma

Page 38: FARMAKOTERAPI PADA GANGGUAN MATA. GENERAL PRINCIPLES OF TREATMENT Drug treatment in ophthalmology is largely directed to one of the following approaches:

OphthalmoscopyOphthalmoscopy

Tonometry

TonometryPerimetry

Page 39: FARMAKOTERAPI PADA GANGGUAN MATA. GENERAL PRINCIPLES OF TREATMENT Drug treatment in ophthalmology is largely directed to one of the following approaches:

Glaukoma

normal

Page 40: FARMAKOTERAPI PADA GANGGUAN MATA. GENERAL PRINCIPLES OF TREATMENT Drug treatment in ophthalmology is largely directed to one of the following approaches:

GLAUCOMA THERAPY

Medical therapySurgery

• By decreasing aqueous prod / inflow

• By increasing outflow

• By destructing the ciliary body

• Filtration surgery

Page 41: FARMAKOTERAPI PADA GANGGUAN MATA. GENERAL PRINCIPLES OF TREATMENT Drug treatment in ophthalmology is largely directed to one of the following approaches:
Page 42: FARMAKOTERAPI PADA GANGGUAN MATA. GENERAL PRINCIPLES OF TREATMENT Drug treatment in ophthalmology is largely directed to one of the following approaches:

GLAUCOMA SURGERY

• Trabeculectomy to connect the anterior chamber with subconjuctival space

• Laser trabeculoplasty (Photocoagulator) making scar in trabeculum

• Gonioplasty/iridoplasty making scar in iris to open the iridocorneal angle

Page 43: FARMAKOTERAPI PADA GANGGUAN MATA. GENERAL PRINCIPLES OF TREATMENT Drug treatment in ophthalmology is largely directed to one of the following approaches:

Management of open angle glaucoma

Page 44: FARMAKOTERAPI PADA GANGGUAN MATA. GENERAL PRINCIPLES OF TREATMENT Drug treatment in ophthalmology is largely directed to one of the following approaches:

Management of angle closure glaucoma

Page 45: FARMAKOTERAPI PADA GANGGUAN MATA. GENERAL PRINCIPLES OF TREATMENT Drug treatment in ophthalmology is largely directed to one of the following approaches:

INFECTION AND INFLAMMATION

OCULARACUTE CONJUNCTIVITIS

Conjunctivitis or inflammation on mucosa which covers the back part of the eye.

• Cause:Bacteria:

- Staphylococcus - Streptococcus pneumonia- Haemophhilus aegyptus

Page 46: FARMAKOTERAPI PADA GANGGUAN MATA. GENERAL PRINCIPLES OF TREATMENT Drug treatment in ophthalmology is largely directed to one of the following approaches:

TREATMENT:

Sulfonamides - the first effective chemotherapeutic agent,- the prevention and cure of bacterial infection.

Side effects:- Patients with acid urine of the older sulfonamide are insoluble and may precipitate causing crystalling deposits can cause urinary obstructive.

Page 47: FARMAKOTERAPI PADA GANGGUAN MATA. GENERAL PRINCIPLES OF TREATMENT Drug treatment in ophthalmology is largely directed to one of the following approaches:

Tetracycline - Active against bacteria and some micro organisms that

are resistant to cell-wall-active anti microbial agent

Side effects:- Gastrointestinal iritation,- Hepatic toxicity,- Renal toxicity,- Brown discoloration of the teeth.

Page 48: FARMAKOTERAPI PADA GANGGUAN MATA. GENERAL PRINCIPLES OF TREATMENT Drug treatment in ophthalmology is largely directed to one of the following approaches:

DACRYOCYSTITIS

Begins with the closings of ductus nasolacrimal.

• Cause: Bacteria Streptococcus pneumonia

• Treatment:- Antibiotic ( orally and parenterally )- Decongestant nose drops

Page 49: FARMAKOTERAPI PADA GANGGUAN MATA. GENERAL PRINCIPLES OF TREATMENT Drug treatment in ophthalmology is largely directed to one of the following approaches:

BACTERIAL CORNEAL ULCERS

• Cause:Viruses (Herpes simplex), fungi (Aspergillus, Candida spp), bacteria (Streptococcus pneumoniae)

• Treatment:- Antibiotics (topical)

Page 50: FARMAKOTERAPI PADA GANGGUAN MATA. GENERAL PRINCIPLES OF TREATMENT Drug treatment in ophthalmology is largely directed to one of the following approaches:

BACTERIAL CORNEAL ULCERS

Mata normal

Page 51: FARMAKOTERAPI PADA GANGGUAN MATA. GENERAL PRINCIPLES OF TREATMENT Drug treatment in ophthalmology is largely directed to one of the following approaches:

FUNGAL KERATITIS

The symptoms of fungal corneal ulcers are redness andsevere pain.

• Cause:- Candida sp- Aspergillus sp

• Treatment:- Amphotericin B 0.15 % ( drops ) every hour- Nystatin 100.00 U/ml( topically ) every two hour- Clotrimazole 1 % ( drops )

Page 52: FARMAKOTERAPI PADA GANGGUAN MATA. GENERAL PRINCIPLES OF TREATMENT Drug treatment in ophthalmology is largely directed to one of the following approaches:

Treatment

- AMPHOTHERICIN B. 0,15% (drops), is one of a family of some 200 polyene macrolide antibiotics.

Side effects (rare):- Fever,- Chill.

Page 53: FARMAKOTERAPI PADA GANGGUAN MATA. GENERAL PRINCIPLES OF TREATMENT Drug treatment in ophthalmology is largely directed to one of the following approaches:

- Nystatin 100.00 U/ml (topically), has the same mechanisms of action with amphothericin B.

Side effects (rare):

- Fever,

- Chill.

Page 54: FARMAKOTERAPI PADA GANGGUAN MATA. GENERAL PRINCIPLES OF TREATMENT Drug treatment in ophthalmology is largely directed to one of the following approaches:

OPHTHALMIA NEONATORUM

It refers to acute conjunctivitis in the first 4 weeks in the life of a child.

• Cause:- Chlamydia- Bacteria:Neisseria gonorrhoeae (potentially leading to

blindness), S.aureus, S.pneumoniae, S.pyogenes, H. influenzae, Herpes simplex virus.

• Treatment:- Neonatus born to mother with active gonococcal: penicillin

G (i.m)- Chlamydia : Erythromycin 10 mg /kg BB. 3 x daily ( orally )

+ tetracycline (topically)

Page 55: FARMAKOTERAPI PADA GANGGUAN MATA. GENERAL PRINCIPLES OF TREATMENT Drug treatment in ophthalmology is largely directed to one of the following approaches:

OPHTHALMIA NEONATORUM

Page 56: FARMAKOTERAPI PADA GANGGUAN MATA. GENERAL PRINCIPLES OF TREATMENT Drug treatment in ophthalmology is largely directed to one of the following approaches:

TRACHOMA

Is an infection on conjuctiva or cornea caused by chlamydia trachoma

• Treatment:- Tetracycline (topical or systemic) 3 to 6 weeks- Erythromycin ( i.m ) once a week for three weeks

Page 57: FARMAKOTERAPI PADA GANGGUAN MATA. GENERAL PRINCIPLES OF TREATMENT Drug treatment in ophthalmology is largely directed to one of the following approaches:

TRACHOMA

Page 58: FARMAKOTERAPI PADA GANGGUAN MATA. GENERAL PRINCIPLES OF TREATMENT Drug treatment in ophthalmology is largely directed to one of the following approaches:

Treatment

Tetracycline - Active against bacteria and some micro organisms that are resistant to cell-wall-active anti microbial agent.

• Side effects:- Gastrointestinal iritation,- Hepatic toxicity,- Renal toxicity,- Brown discoloration of the teeth.

Page 59: FARMAKOTERAPI PADA GANGGUAN MATA. GENERAL PRINCIPLES OF TREATMENT Drug treatment in ophthalmology is largely directed to one of the following approaches:

Erythromycin (taken orally), is usually bacteriostatics but can be bacteriocidal in high concentration.

Side effects:

- fever,

- eosinophilia,

- skin eruption.

Page 60: FARMAKOTERAPI PADA GANGGUAN MATA. GENERAL PRINCIPLES OF TREATMENT Drug treatment in ophthalmology is largely directed to one of the following approaches:

VIRUS INFECTION

Viral lesion of the lids, conjunctiva and cornea can be caused by a number of different viruses: varicelal- zoster, herpes simplex vaccina

• Treatment- Iodoxuridine (topical), - Ganciclovir (systemic)

Page 61: FARMAKOTERAPI PADA GANGGUAN MATA. GENERAL PRINCIPLES OF TREATMENT Drug treatment in ophthalmology is largely directed to one of the following approaches:

Treatment

- Iodoxuridine (topical), is an iodinated thymidine

analogue.

• Mechanisms of action: Inhibits replication of various DNA viruses,

including herpes viruses.

• Side effects:- Pain, - Pruritis, - Inflammation in the eye or eyelids

Page 62: FARMAKOTERAPI PADA GANGGUAN MATA. GENERAL PRINCIPLES OF TREATMENT Drug treatment in ophthalmology is largely directed to one of the following approaches:

Ganciclovir (systemic), is an acyclic guanine nucleotide analogue. The agent has inhibitory activity against all herpes viruses especially CMV (Cito Megalo Virus)

• Mechanisms of action: Inhibits viral DNA synthesis.

• Side effects:- Pain, - Pruritis, - Inflammation in the eye or eyelids

Page 63: FARMAKOTERAPI PADA GANGGUAN MATA. GENERAL PRINCIPLES OF TREATMENT Drug treatment in ophthalmology is largely directed to one of the following approaches:

Thank you